{
    "clinical_study": {
        "@rank": "28608", 
        "arm_group": [
            {
                "arm_group_label": "Control Total Hip Replacement Device", 
                "arm_group_type": "Active Comparator", 
                "description": "Total Hip replacement surgery using control device consisting of a hard-on-soft bearing or a ceramic-on-ceramic bearing"
            }, 
            {
                "arm_group_label": "Investigational Hard-on-Hard Total Hip Replacement Device", 
                "arm_group_type": "Experimental", 
                "description": "Total Hip replacement surgery using an experimental device consisting of a hard-on-hard bearing"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the early safety and efficacy of a new hard-on-hard\n      total hip replacement system in patients with non-inflammatory arthritis."
        }, 
        "brief_title": "Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System", 
        "condition": "Arthritis, Degenerative", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Osteoarthritis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 21 years old\n\n          -  Skeletally mature\n\n          -  Requires primary, unilateral total hip arthroplasty due to degenerative join disease\n\n          -  Preoperative Harris Hip Score of less than or equal to 70\n\n          -  Meets an acceptable preoperative medical clearance and is free or treated for\n             conditions that would pose excessive operative risk\n\n          -  Given consent to participate in the study\n\n          -  Able to understand the purpose of the study, his/her role, and is available for\n             follow-up\n\n        Exclusion Criteria:\n\n          -  Diagnosis with high risk of Total Hip Arthroplasty (THA) failure\n\n          -  Requires bilateral THA\n\n          -  Requires revision of a prior hip replacement\n\n          -  Active infection or sepsis\n\n          -  History of local hip infection\n\n          -  Known metastatic or neoplastic disease\n\n          -  Conditions that may interfere with THA survival or outcomes\n\n          -  Need for structural bone grafts to support the implant\n\n          -  Contralateral lower extremity condition\n\n          -  Has other joint replacements or plans for other joint replacements within 2 years\n\n          -  Systemic steroid therapy within 3 months prior to surgery\n\n          -  Life expectancy less than 2 years\n\n          -  Intra-articular therapy within 6 months of enrollment\n\n          -  Female of child-bearing age not using contraception\n\n          -  Inadequate bone stock to support the device\n\n          -  Moderate to severe renal insufficiency\n\n          -  Emotional or neurological condition that would pre-empt ability or willingness to\n             participate in the study\n\n          -  BMI >40\n\n          -  Above the knee amputation of the contralateral or ipsilateral leg\n\n          -  Known allergies to the components of the devices\n\n          -  Entered into another investigational study\n\n          -  Is a prisoner"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02154516", 
            "org_study_id": "2011-ODHH166"
        }, 
        "intervention": {
            "arm_group_label": [
                "Control Total Hip Replacement Device", 
                "Investigational Hard-on-Hard Total Hip Replacement Device"
            ], 
            "intervention_name": "ODH Hip System", 
            "intervention_type": "Device", 
            "other_name": [
                "Total Hip Replacement", 
                "THR", 
                "Total Hip Arthroplasty", 
                "THA"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 30, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Durban", 
                        "country": "South Africa", 
                        "zip": "4001"
                    }, 
                    "name": "Entabeni Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pretoria", 
                        "country": "South Africa", 
                        "zip": "0002"
                    }, 
                    "name": "Zuid Afrikaans Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "South Africa"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "South Africa: National Health Research Ethics Council"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Reoperations that led to removal or replacement of any of the acetabular or femoral components.", 
                "measure": "Revision Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 2 Years"
            }, 
            {
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 2 Years"
            }, 
            {
                "measure": "Metal Ion Concentration in Whole Blood", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02154516"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Smith & Nephew, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Smith & Nephew, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}